Anti-IgLON5 antibodies are the main diagnostic biomarker but the assessment of ocular motor function, particularly in patients with suspected PSP and absence of typical Parkinson’s features, may prompt for anti-IgLON5 antibody testing and support accurate diagnosis. The gene discussed is IGLON5; the disease is supranuclear palsy, progressive, 1.